|
π
|
Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UK.
87 auth.
A. Cleare,
Jess Kerr-Gaffney,
Kimberley Goldsmith,
Zohra Zenasni,
Nahel Yaziji,
Huajie Jin,
Alessandro Colasanti,
J. Geddes,
David Kessler,
R. McAllister-Williams,
A. Young,
Alvaro Barrera,
L. Marwood,
R. Taylor,
Helena Tee,
...
James Rucker,
Camilla Day,
Ilia Bountouni,
Mario F Juruena,
Luke Jelen,
Allison Edwards,
Carol Kan,
Chaitra Jairaj,
Lauren Waterman,
R. McCutcheon,
R. Gadelrab,
Rashmi Patel,
Patrick McLoughlin,
E. Day,
Rupal Shah,
Joseph Cattell,
V. de Angel,
Emma Incecik,
Anda Ancane,
Emmanuella Oprea,
A. Ulrichsen,
V. Nikolova,
T. Mantingh,
Dimosthenis Tsapekos,
Andrew Pickles,
Daniel Deitch,
R. Strawbridge,
Renee Romeo,
Rachel Holland,
S. Watson,
Hossam Marey,
Niraj Ahuja,
Eman Arebi,
Daniel Armstrong,
D. Buruju,
Afamefuna Emechebe,
Oghenefejiro Esi,
Jayne Healicon,
Selma Osman,
William Stageman,
Neeti Sud,
Vineet Raj,
Jennifer Burgess,
J. Hutchinson,
Kimberley Nortey,
Susan Wilson,
Wendy Hall,
Joe Swift,
Rosie Carr,
Jahnese Hamilton,
Joe Reilly,
Rajesh Nair,
Phil J Cowen,
Michael Browning,
Lucas McKeown,
Sarah Mather,
Jen Potts,
Chris Millar,
Sarah Hollingsworth,
Rebecca L. Dean,
Ceri Morgan,
Jade Harvey,
Fay Davies,
Andrea Cipriani,
M. Attenburrow,
Jonathan Evans,
Jonathan Davies,
Rwth Leach,
Catherine Roiz de S'a,
Joanna Pooley,
Guy Emery,
Serena Gregory
|
0 |
2025 |
0
π
|
